BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2398Biotechnology
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.4x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average -22.9x

Price / book6.3x
CheapRich

Above its usual level · 68th percentile, 5-year average 5.9x

#4615 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-101x-65x-29x7xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$42.82
Price vs. fair value-42.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.33 – 5.90 68% (pricier than usual) #4615 of 5330 (1 = cheapest)
PE -5.39 -5.30 -22.87 81% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on VKTX.

Sign in to join the discussion.

Scroll to Top